BACKGROUND: Inflammatory bowel disease (IBD) increases the risk of venous
thromboembolism (VTE) by 2 to 3 times. We compared the reduction in risk of incident VTE …

Background, aims Patients with inflammatory bowel disease (IBD) have a more than twofold
higher risk of venous thromboembolic events (VTE) than the general population. The …

Background & Aims We investigated whether treatment of active inflammatory bowel
disease with biologic agents is associated with a reduced risk of venous thromboembolic …

Background: Patients with inflammatory bowel disease (IBD) are at increased risk of
thromboembolic events. The aim of this study was to assess whether treatment with anti …

Patients with inflammatory bowel disease (IBD) have an increased risk of venous
thromboembolism (VTE). Alongside the traditional acquired and genetic risk factors for VTE …

Patients diagnosed with inflammatory bowel disease (IBD), which encompasses Crohn's
disease and ulcerative colitis, experience chronic inflammation of the gastrointestinal tract …

Abstract Background and Aims Inflammatory bowel disease [IBD] is associated with a 1.5-to
3-fold increased risk of venous thromboembolism [VTE] events. The aim of this study was to …

METHODS: We used the population-based University of Manitoba IBD Epidemiology
Database (1984–2018) to determine the incidence of VTE in IBD and the incidence rate ratio …

Inflammatory bowel disease (IBD) patients have an increased risk of venous
thromboembolism (VTE), which represents a significant cause of morbidity and mortality …

Objective. Patients with inflammatory bowel diseases (IBD) are considered to have an
increased risk for venous thromboembolism (VTE). The aim of the present study was to …